1.Tumor Spheroids of an Aggressive Form of Central Neurocytoma Have Transit-Amplifying Progenitor Characteristics with Enhanced EGFR and Tumor Stem Cell Signaling
Hye Young SHIN ; Kyung-Seok HAN ; Hyung Woo PARK ; Yun Hwa HONG ; Yona KIM ; Hyo Eun MOON ; Kwang Woo PARK ; Hye Ran PARK ; C. Justin LEE ; Kiyoung LEE ; Sang Jeong KIM ; Man Seung HEO ; Sung-Hye PARK ; Dong Gyu KIM ; Sun Ha PAEK
Experimental Neurobiology 2021;30(2):120-143
Central neurocytoma (CN) has been known as a benign neuronal tumor. In rare cases, CN undergoes malignant transformation to glioblastomas (GBM). Here we examined its cellular origin by characterizing differentiation potential and gene expression of CN-spheroids. First, we demonstrate that both CN tissue and cultured primary cells recapitulate the hierarchal cellular composition of subventricular zone (SVZ), which is comprised of neural stem cells (NSCs), transit amplifying progenitors (TAPs), and neuroblasts. We then derived spheroids from CN which displayed EGFR+/ MASH+ TAP and BLBP+ radial glial cell (RGC) characteristic, and mitotic neurogenesis and gliogenesis by single spheroids were observed with cycling multipotential cells. CN-spheroids expressed increased levels of pluripotency and tumor stem cell genes such as KLF4 and TPD5L1, when compared to their differentiated cells and human NSCs. Importantly, Gene Set Enrichment Analysis showed that gene sets of GBM-Spheroids, EGFR Signaling, and Packaging of Telomere Ends are enriched in CN-spheroids in comparison with their differentiated cells. We speculate that CN tumor stem cells have TAP and RGC characteristics, and upregulation of EGFR signaling as well as downregulation of eph-ephrin signaling have critical roles in tumorigenesis of CN. And their ephemeral nature of TAPs destined to neuroblasts, might reflect benign nature of CN.
2.Tumor Spheroids of an Aggressive Form of Central Neurocytoma Have Transit-Amplifying Progenitor Characteristics with Enhanced EGFR and Tumor Stem Cell Signaling
Hye Young SHIN ; Kyung-Seok HAN ; Hyung Woo PARK ; Yun Hwa HONG ; Yona KIM ; Hyo Eun MOON ; Kwang Woo PARK ; Hye Ran PARK ; C. Justin LEE ; Kiyoung LEE ; Sang Jeong KIM ; Man Seung HEO ; Sung-Hye PARK ; Dong Gyu KIM ; Sun Ha PAEK
Experimental Neurobiology 2021;30(2):120-143
Central neurocytoma (CN) has been known as a benign neuronal tumor. In rare cases, CN undergoes malignant transformation to glioblastomas (GBM). Here we examined its cellular origin by characterizing differentiation potential and gene expression of CN-spheroids. First, we demonstrate that both CN tissue and cultured primary cells recapitulate the hierarchal cellular composition of subventricular zone (SVZ), which is comprised of neural stem cells (NSCs), transit amplifying progenitors (TAPs), and neuroblasts. We then derived spheroids from CN which displayed EGFR+/ MASH+ TAP and BLBP+ radial glial cell (RGC) characteristic, and mitotic neurogenesis and gliogenesis by single spheroids were observed with cycling multipotential cells. CN-spheroids expressed increased levels of pluripotency and tumor stem cell genes such as KLF4 and TPD5L1, when compared to their differentiated cells and human NSCs. Importantly, Gene Set Enrichment Analysis showed that gene sets of GBM-Spheroids, EGFR Signaling, and Packaging of Telomere Ends are enriched in CN-spheroids in comparison with their differentiated cells. We speculate that CN tumor stem cells have TAP and RGC characteristics, and upregulation of EGFR signaling as well as downregulation of eph-ephrin signaling have critical roles in tumorigenesis of CN. And their ephemeral nature of TAPs destined to neuroblasts, might reflect benign nature of CN.
3.Quality Improvement Activities to Facilitate the Filing of Complexity Payment Claims for Patients with Malnutrition.
Kuk Hwan KWON ; Hyung Soon LEE ; Jee Hyoung YOO ; Soo Na CHI ; Hyun Hee PARK ; So Won KIM ; Kyung Ran KIM ; Nan Hee YUN ; Kyoung Taek RA ; Hyun Jung SONG
Journal of Clinical Nutrition 2018;10(1):20-24
PURPOSE: The grade of complexity in the diagnosis related group (DRG) payment system is influenced by the secondary diagnosis of specific complication and comorbidity level, in which moderate or severe malnutrition is included. This study examined an existing proportion of patients with malnutrition who were supposed to be qualified for the complexity level and devised quality improvement measures to increase the proportion of qualifying complexity payments. METHODS: The goal of the activities was to increase the rate of complexity payment claims for patients with malnutrition (%). Cases ineligible for the DRG payment system and cases with no diagnosis of malnutrition were excluded. We established a collaborative system between the nutrition support team and departments related to each improvement factor (i.e., patient care, medical records, insurance review, and medical information). RESULTS: Before implementing the activities, this study investigated the current level of complexity payment claims for malnutrition patients who were discharged within a specific period (June 1, 2015~August 31, 2015). The results showed that complexity payment claims were filed in 10.00% (2 of the 20 malnutrition cases). After the activities, the rate of complexity payment claims for the patients with malnutrition within the study period (June 1, 2016~August 31, 2016) was 46.43% (26 out of 56), showing an approximately 364% increase from the pre activity rate. This change was statistically significant according to the chi-square test on Microsoft Excel 2010 (P < 0.01). CONCLUSION: Collaborative efforts by the related departments enabled the smooth implementation of each activity. In addition, moderate or severe malnutrition was revealed to be a variable in the complexity-specific payment system. In the future, hospital-wide awareness and effort are crucial to promot the steady practice of these activities and expand their implementation.
Comorbidity
;
Diagnosis
;
Diagnosis-Related Groups
;
Humans
;
Insurance
;
Malnutrition*
;
Medical Records
;
Patient Care
;
Quality Improvement*
4.Frequency of Red Blood Cell Antigens According to Parent Ethnicity in Korea Using Molecular Typing.
Kyung Hwa SHIN ; Hyun Ji LEE ; Hyung Hoi KIM ; Yun Ji HONG ; Kyoung Un PARK ; Min Ju KIM ; Jeong Ran KWON ; Young Sil CHOI ; Jun Nyun KIM
Annals of Laboratory Medicine 2018;38(6):599-603
Frequencies of red blood cell (RBC) blood group antigens differ by ethnicity. Since the number of immigrants is increasing in Korea, RBC antigens should be assessed in children/youths with parents of different ethnicities to ensure safe transfusions. We investigated the frequency of RBC antigens, except for ABO and RhD, in 382 children and youths with parents having Korean and non-Korean ethnicities. Subjects were divided into those with ethnically Korean parents (Korean group; N=252) and those with at least one parent of non-Korean ethnicity (non-Korean group; N=130). The 37 RBC antigens were genotyped using the ID CORE XT system (Progenika Biopharma-Grifols, Bizkaia, Spain). The frequencies of the Rh (E, C, e, hr(S), and hr(B)), Duffy (Fy(a)), MNS (Mi(a)), and Cartwright (Yt(b)) antigens differed significantly between the two groups. Eight and 11 subjects in the Korean and non-Korean groups, respectively, exhibited negative expression of high-frequency antigens, whereas 14 subjects in the non-Korean group showed positive expression of low-frequency antigens. The frequency of RBC antigens has altered alongside demographic changes in Korea and might lead to changes in distribution of RBC antibodies that cause acute or delayed hemolytic transfusion reaction.
Adolescent
;
Antibodies
;
Blood Group Antigens
;
Child
;
Emigrants and Immigrants
;
Erythrocytes*
;
Humans
;
Korea*
;
Molecular Typing*
;
Parents*
;
Transfusion Reaction
5.Hypocomplementemic Urticarial Vasculitis Syndrome with Membranous Nephropathy: Case Report.
Su Woong JUNG ; Yun Young CHOI ; In Seung CHOI ; Seulki KIM ; Kyung Hwan JEONG ; Ran SONG ; Sang Hoon LEE ; Hyung In YANG ; Seung Jae HONG ; Yeon Ah LEE
Journal of Korean Medical Science 2017;32(12):2064-2068
Urticarial vasculitis is a rare disorder that principally manifests with recurrent urticarial, sometimes hemorrhagic, skin lesions and/or angioedema. Its clinical presentation is not always limited to cutaneous lesions and it can potentially affect other organs, such as the joints, lungs, kidneys, and eyes. Systemic involvement can either be present at the onset of disease or develop over time. In cases with systemic manifestations, urticarial vasculitis is more likely to be associated with a low complement level. We present the case of a teenage boy with hypocomplementemic urticarial vasculitis syndrome (HUVS) that occurred shortly following swine-origin influenza A virus infection in 2009. Afterwards, HUVS was systemically complicated with myositis and membranous nephropathy that developed several months and about 2 years after its onset, respectively. A combination of glucocorticoid and immunosuppressive agents has been used to effectively control disease activity.
Angioedema
;
Complement System Proteins
;
Glomerulonephritis, Membranous*
;
Humans
;
Immunosuppressive Agents
;
Influenza A virus
;
Joints
;
Kidney
;
Lung
;
Male
;
Myositis
;
Skin
;
Vasculitis*
6.The Change in Distribution of Red Blood Cell Antigens in Korean Youth: In an Era of Multicultural Society.
Kyung Hwa SHIN ; Hyung Hoi KIM ; Hyun Ji LEE ; Tae Young AHN ; Kyoung Un PARK ; Yun Ji HONG ; Jeong Ran KWON ; Young Sill CHOI ; Jun Nyun KIM
Korean Journal of Blood Transfusion 2016;27(2):105-112
BACKGROUND: It is important to check the blood group antigens to ensure the safety of blood transfusions. Recently, the number of multicultural families and foreigners has increased in Korea; therefore, a survey for red blood cell antigens for multicultural families is need. We performed a phenotyping of their red blood cell antigens and found the characteristics in providing basic data. METHODS: We recruited young people under the age of 26 years from multicultural family between September 2015 and March 2016. The participants were divided into two groups: the multicultural youth group (MCY) and the non-multicultural youth group (non-MCY). Subjects underwent phenotyping of ABO, Rh, Kell, Kidd, Duffy, MNS, and Diego blood group, and the results were compared and characterized between the two groups. RESULTS: A total of 226 subjects (89 MCY, 137 non-MCY) were recruited. The blood groups with differences between MCY and non-MCY were E, e in Rh and S in MNS. In MCY, the frequency of CDe expression in the Rh blood group was higher and the cDE expression was lower. There were 3.4% and 2.2% of MCY with no expression of Fy(a) and s, respectively, which were rare blood types in Koreans. CONCLUSION: The difference in frequency of red blood cell antigens between MCY and non-MCY have been identified. These results suggest that the national blood policy reflects an increasing number of multicultural families and Korea needs to be prepared for a population change.
Adolescent*
;
Blood Group Antigens
;
Blood Transfusion
;
Emigrants and Immigrants
;
Erythrocytes*
;
Humans
;
Korea
7.hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines.
Sang Jin KIM ; Hyoung Ran KIM ; Seok Hyung KIM ; Ji Hye HAN ; Yong Beom CHO ; Seong Hyeon YUN ; Woo Yong LEE ; Hee Cheol KIM
Annals of Surgical Treatment and Research 2014;87(3):123-130
PURPOSE: Sporadic colorectal cancers with high-frequency microsatellite instability (MSI-H) are related to hypermethylation of mismatch repair (MMR) genes and a higher frequency of BRAF mutations than Lynch syndrome. We estimated the feasibility of hereditary colorectal cancer based on hMLH1 methylation and BRAF mutations. METHODS: Between May 2005 and June 2011, we enrolled all 33 analyzed patients with MSI-H cancer (male:female, 23:10; mean age, 65.5 +/- 9.4 years) from a prospectively maintained database that didn't match Bethesda guidelines and who had results of hMLH1 methylation and BRAF mutations. RESULTS: Among the 33 patients, hMLH1 promoter methylation was observed in 36.4% (n = 12), and was not significantly related with clinicopathologic variables, including MLH1 expression. BRAF mutations were observed in 33.3% of the patients (n = 11). Four of 11 and five of 22 patients with MSI-H colon cancers were BRAF mutation (+)/hMLH1 promoter methylation (-) or BRAF mutation (-)/hMLH1 promoter methylation (+). Of the 33 patients, 21.2% were BRAF mutation (+)/hMLH1 promoter methylation (+), indicating sporadic cancers. Seventeen patients (51.5%) were BRAF mutation (-)/hMLH1 promoter methylation (-), and suggested Lynch syndrome. CONCLUSION: Patients with MSI-H colorectal cancers not fulfilling the Bethesda guidelines possibly have hereditary colorectal cancers. Adding tests of hMLH1 promoter methylation and BRAF mutations can be useful to distinguish them from sporadic colorectal cancers.
Colonic Neoplasms
;
Colorectal Neoplasms*
;
Colorectal Neoplasms, Hereditary Nonpolyposis
;
DNA Mismatch Repair
;
Humans
;
Methylation*
;
Microsatellite Instability*
;
Prospective Studies
8.Extramedullary Solitary Plasmacytoma of the Lymph Nodes.
Min KIM ; Hyuk LEE ; Tae Gil HEO ; Sunhee CHANG ; Hyung Geun YUN ; Seong Min YOON ; Hye Ran LEE
Korean Journal of Medicine 2013;84(5):751-754
Extramedullary plasmacytomas are uncommon malignant neoplasms that can occur in any organ. They arise most frequently from the upper aerodigestive tract. Lymph nodes are exceedingly rare sites of extramedullary plasmacytomas. Most extramedullary plasmacytomas of the lymph node arise in the cervical lymph nodes. Here, we report a case of an extramedullary plasmacytoma of the lymph node arising from a cervical lymph node. A 43-year-old male patient was admitted to our hospital and presented with a non-tender mass on the left side of his neck, which had been growing slowly for 1 month. The mass was excised. The pathology showed diffuse infiltration of immature plasma cells that were encapsulated by a layer of lymphoid cells, indicating an extramedullary plasmacytoma. He was treated with local radiation of the left cervical area. As of March 2009, he is doing well and shows no further evidence of the disease.
Humans
;
Lymph Nodes
;
Lymphocytes
;
Male
;
Neck
;
Plasma Cells
;
Plasmacytoma
9.Comparison of Proteome Components of Helicobacter pylori Before and After Mouse Passage.
Kyoung Ja LEE ; Bok Ran KIM ; Young A CHO ; Yun Gyu SONG ; Jae Young SONG ; Kon Ho LEE ; Hyung Lyun KANG ; Seung Chul BAIK ; Myung Je CHO ; Kwang Ho RHEE ; Ji Hyun SEO ; Hee Shang YOUN ; Woo Kon LEE
Journal of Bacteriology and Virology 2011;41(4):267-278
The mouse model is alleged to be a useful tool for understanding of pathophysiological roles of Helicobacter pylori in the development of gastric disorders. However, it has been observed that H. pylori strains significantly differed in their fitness in mice and even mouse strains differed in their susceptibilities to a H. pylori strain. Bacterial components of H. pylori which could affect on its fitness in mice have to be elucidated for the establishment of the mouse model for H. pylori infections. In the comparison of colonization ability between two H. pylori Korean isolates, 51 (isolated from a patient with duodenal ulcer) and 52 (isolated from a patient with gastric cancer), 52 could colonize better than 51 on the gastric mucosa of mouse. Proteome components of H. pylori 52, as a good colonizer and H. pylori 51, as a poor one were quantitatively compared each other. Five bacterial proteins including catalase, urease subunit alpha/beta, enolase and ferritin, were up-regulated in 52. In addition, the respective proteome components of the two strains were also compared with their mouse-passaged homologous strains. Seven and five proteins, which included catalase, flagellin A/B in common, were up-regulated in mouse-adapted 51 and 52, respectively. Among the fourteen identified proteins, urease subunit alpha/beta, flagellin A/B, catalase, ferritin, superoxide dismutase and neutrophil-activation protein have been previously known to be necessary to gastric colonization of H. pylori in animal models. The other up-regulated proteins including enolase, elongation factor Tu and fructose-bisphosphate aldolase have been reported to be associated with acid tolerance of H. pylori. These data provide confirmatory evidence for the importance of those proteins in the development of H. pylori-associated gastric disorders.
Animals
;
Bacterial Proteins
;
Catalase
;
Colon
;
Ferritins
;
Flagellin
;
Fructose-Bisphosphate Aldolase
;
Gastric Mucosa
;
Helicobacter
;
Helicobacter pylori
;
Humans
;
Mice
;
Models, Animal
;
Peptide Elongation Factor Tu
;
Phosphopyruvate Hydratase
;
Proteins
;
Proteome
;
Sprains and Strains
;
Superoxide Dismutase
;
Urease
10.Clinical Analysis of Video Assisted Thoracic Surgery for the Treatment of Thoracic Empyema.
Sang Gi OH ; Sang Yun SONG ; Chi Hyeong YUN ; Kook Ju NA ; Kang Eun KONG ; Song Ran PARK ; Sang Hyung KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2010;43(2):139-143
BACKGROUND: Thoracic empyema remains a serious problem despite the availability of modern diagnostic methods and appropriate antibiotics. The condition presents in many different forms and stages that require different therapeutic options. Video-assisted thoracic surgery (VATS) has become increasingly popular for use in the treatment of empyema. MATERIAL AND METHOD: From January 2005 to May 2009, VATS was performed in 36 patients with pleural empyema and for whom chest-tube drainage and antibiotic therapy had failed or the CT scan showed multiseptate disease. The perioperative clinical factors were analyzed for all the study patients. RESULT: All the patients underwent VATS, but it was necessary to convert to thoracotomy in one patient. The mean operation time was 90+/-38.5 min. For the operative evaluation, 11 patients were compatible with ATS stage III. The duration of chest-tube insertion was 11.9+/-5.8 (3~24) days. One patient did not improve and therefore this patient underwent additional open drainage. At discharge, costophrenic angle blunting was observed in 22 patients, pleural thickening was noted in 20 patients, both were noted in 17 patients and neither was noted in 11 patients. However, at follow-up, each of these changes was observed in 9, 7, 4 and 24 patients, respectively. All except one patient showed radiographic improvement. CONCLUSION: VATS is suitable for the treatment of early and fibrinopurulent thoracic empyema, and even in selected patients with stage III disease.
Anti-Bacterial Agents
;
Drainage
;
Empyema
;
Empyema, Pleural
;
Follow-Up Studies
;
Humans
;
Pleural Effusion
;
Thoracic Surgery, Video-Assisted
;
Thoracoscopy
;
Thoracotomy

Result Analysis
Print
Save
E-mail